Business Description
Rakovina Therapeutics Inc
NAICS : 541710
SIC : 3741
ISIN : CA75103L1013
Description
Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a greater pace. The company has established a pipeline of distinctive DNA-damage response inhibitors to advance one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners. Its drug development pipeline consists of candidates like kt-5000AI, kt-2000AI, and kt-3283, targeting solid tumours and PARP-resistant adult and childhood cancers.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.2 | |||||
Equity-to-Asset | -0.13 | |||||
Debt-to-Equity | -5.4 | |||||
Debt-to-EBITDA | -0.41 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -9.8 | |||||
3-Year EPS without NRI Growth Rate | -6.3 | |||||
3-Year FCF Growth Rate | -5.4 | |||||
3-Year Book Growth Rate | -79.9 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.61 | |||||
9-Day RSI | 38.54 | |||||
14-Day RSI | 40.92 | |||||
3-1 Month Momentum % | 22.73 | |||||
6-1 Month Momentum % | 3.85 | |||||
12-1 Month Momentum % | -80.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.55 | |||||
Cash Ratio | 0.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -44.7 | |||||
Shareholder Yield % | -217.65 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -583.91 | |||||
ROA % | -165.1 | |||||
ROIC % | -164.36 | |||||
3-Year ROIIC % | 2358.19 | |||||
ROC (Joel Greenblatt) % | -3334.94 | |||||
ROCE % | -286.02 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.65 | |||||
EV-to-EBITDA | -0.71 | |||||
EV-to-FCF | -0.96 | |||||
Earnings Yield (Greenblatt) % | -153.84 | |||||
FCF Yield % | -197.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rakovina Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.42 | ||
| Beta | -0.2122 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 124.13 | ||
| 14-Day RSI | 40.92 | ||
| 14-Day ATR (C$) | 0.007571 | ||
| 20-Day SMA (C$) | 0.12425 | ||
| 12-1 Month Momentum % | -80.15 | ||
| 52-Week Range (C$) | 0.085 - 0.69 | ||
| Shares Outstanding (Mil) | 24.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rakovina Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rakovina Therapeutics Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2025-06-24 | 0.55 (-8.33%) |
Show
Entries
Rakovina Therapeutics Inc Frequently Asked Questions
What is Rakovina Therapeutics Inc(TSXV:RKV)'s stock price today?
The current price of TSXV:RKV is C$0.11. The 52 week high of TSXV:RKV is C$0.69 and 52 week low is C$0.09.
When is next earnings date of Rakovina Therapeutics Inc(TSXV:RKV)?
The next earnings date of Rakovina Therapeutics Inc(TSXV:RKV) is .
Does Rakovina Therapeutics Inc(TSXV:RKV) pay dividends? If so, how much?
Rakovina Therapeutics Inc(TSXV:RKV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Rakovina Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers